Patents by Inventor Michael L. Morrison

Michael L. Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240126120
    Abstract: A display may have a pixel array such as a liquid crystal pixel array. The pixel array may be illuminated with backlight illumination from a direct-lit backlight unit. The backlight unit may include an array of light-emitting diodes (LEDs) on a printed circuit board. The display may have a notch to accommodate an input-output component. Reflective layers may be included in the notch. The backlight may include a color conversion layer with a property that varies as a function of position. The light-emitting diodes may be covered by a slab of encapsulant with recesses in an upper surface.
    Type: Application
    Filed: December 8, 2023
    Publication date: April 18, 2024
    Inventors: Meizi Jiao, Joshua A. Spechler, Jie Xiang, Zhenyue Luo, Chungjae Lee, Morteza Amoorezaei, Mengyang Liang, Xinyu Zhu, Mingxia Gu, Jun Qi, Eric L. Benson, Victor H. Yin, Youchul Jeong, Xiang Fang, Yanming Li, Michael J. Lee, Marianna C. Sbordone, Ari P. Miller, Edward J. Cooper, Michael C. Sulkis, Francesco Ferretti, Seth G. McFarland, Mary M. Morrison, Eric N. Vergo, Terence Chan, Ian A. Guy, Keith J. Hendren, Sunitha Chandra
  • Publication number: 20220387483
    Abstract: The present invention relates to the use of iodide compounds, to treat and prevent cachexia and cardiotoxicity resulting from treatment with an anti-cancer therapy.
    Type: Application
    Filed: November 3, 2020
    Publication date: December 8, 2022
    Inventors: Stephen A. HILL, Michael Andrew INSKO, Michael L. MORRISON, Akiko IWATA, Mark B. ROTH
  • Publication number: 20220313730
    Abstract: The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.
    Type: Application
    Filed: December 30, 2021
    Publication date: October 6, 2022
    Inventors: Mark B. ROTH, Michael L. MORRISON, Akiko IWATA
  • Publication number: 20210252047
    Abstract: The present invention relates to the use of halogen compounds, including iodide, to treat and prevent Post-intensive care syndrome and skeletal muscle tissue damage resulting from an injury or disease.
    Type: Application
    Filed: June 7, 2019
    Publication date: August 19, 2021
    Inventors: Stephen A. HILL, Mark B. Roth, John W. LANGSTON, Michael L. MORRISON, Akiko IWATA, Michael Andrew INSKO
  • Publication number: 20200016194
    Abstract: The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.
    Type: Application
    Filed: November 30, 2018
    Publication date: January 16, 2020
    Inventors: Mark B. Roth, Michael L. Morrison, Akiko Iwata
  • Patent number: 10201570
    Abstract: The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.
    Type: Grant
    Filed: February 10, 2015
    Date of Patent: February 12, 2019
    Assignee: Fred Hutchinson Cancer Research Center
    Inventors: Mark B. Roth, Michael L. Morrison, Akiko Iwata
  • Publication number: 20160346323
    Abstract: The present invention relates to the use of halogen compounds, including iodide, and chalcogenide compounds, including iodide, sulfide and selenide, to treat and prevent diseases and injuries. The present invention further relates to compositions comprising a halogen compound and/or a chalcogenide compound, including pharmaceutical compositions, as well as methods of manufacturing such compounds and administering such compositions to subjects in need thereof.
    Type: Application
    Filed: February 10, 2015
    Publication date: December 1, 2016
    Inventors: Mark B. ROTH, Michael L. MORRISON, Akiko IWATA
  • Publication number: 20150290240
    Abstract: This invention relates to compositions comprising chalcogenides in a reduced form, related methods of producing compositions comprising chalcogenides in a reduced form, devices for delivering a reduced form of a compound to a subject, as well as to methods for treating or preventing injuries or disease using a composition comprising a chalcogenide in a reduced form.
    Type: Application
    Filed: June 12, 2013
    Publication date: October 15, 2015
    Inventors: Mark B. Roth, Michael L. Morrison, Akiko Iwata
  • Patent number: 5012763
    Abstract: A portable aquabrood that is formed from an enclosed animal habitat chamber assembly and an enclosed water chamber assembly that are assembled together as a unitary member. The animal habitat chamber assembly has a first upright end wall and a primary bottom wall that are both common walls of the water chamber assembly. The water chamber assembly has a major bottom wall that is spaced a predetermined height below the primary bottom wall thus when the water chamber assembly has a predetermined amount of water in it, that water will directly contact the primary bottom wall and a major protion of the first end wall of the animal habitat chamber assembly. An electric submersible heater is mounted in the interior of the water chamber assembly, it heats the water which warms the air in the chamber. The warmed air passes through the respective common walls to keep recently hatched birds or other animals that need to be kept warm in the animal habitat chamber assembly.
    Type: Grant
    Filed: February 27, 1990
    Date of Patent: May 7, 1991
    Inventor: Michael L. Morrison